TRVI STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Trevi Therapeutics, Inc. (NASDAQ: TRVI) and Encourages Long-Term Investors to Contact the Firm
1. Kaskela Law is investigating Trevi Therapeutics for possible securities law violations. 2. The investigation focuses on potential breaches of fiduciary duties by company leaders. 3. Shareholders can seek legal advice regarding their rights in this investigation. 4. This inquiry could impact investor trust and regulatory scrutiny for Trevi. 5. Kaskela Law specializes in securities fraud and corporate governance litigation.